A new paradigm for funding cardiovascular-outcome research in general practice. The Second Australian National Blood Pressure Study. ANBP2 Management Committee.
Reid
C M
CM
Wing
L M
LM
Graham
D H
DH
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001315:Australia; D003362:Cost-Benefit Analysis; D004232:Diuretics / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D004345:Drug Industry / Q000191:economics*; D005194:Family Practice / Q000191:economics; D005380:Financing, Government / Q000191:economics*; D005381:Financing, Organized / Q000191:economics*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics; D017063:Outcome Assessment, Health Care / Q000191:economics*; D011446:Prospective Studies; D012109:Research Support as Topic / Q000191:economics*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004232:Diuretics